January 16, 2026 · Form 4 insider transaction
Jamil Khurram bought 65,000 shares of Galectin Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan.; The options vest as follows: 25% on each of June 30, 2026? December 31, 2026? June 30, 2027? and December 31, 2027.